Open AccessInterleukin‐2 before Antiretroviral Therapy in Patients with HIV Infection: A Randomized Trial (ANRS 119)
Author(s) -
JeanMichel Molina,
Yves Lévy,
Isabelle Fournier,
Stéphanie Hamonic,
M. Bentata,
Geneviève Beck-Wirth,
MarieLise Gougeon,
Alain Venet,
Isabelle Madelaine,
D. Séréni,
François Jeanblanc,
Thomas Boulet,
François Simon,
J Aboulker
Publication year - 2009
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/599989
Subject(s) - medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , randomized controlled trial , virology , immunology , viral load
Interleukin (IL)-2 increases CD4 T cell counts when combined with antiretroviral therapy (ART). Whether IL-2 alone can increase CD4 cell counts is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom